Conference · Washington, District of Columbia
Orphan Drug Forum 2014
Pharmaceuticals · General
Key numbers
- Editions on record
- 5first in 2011
About Orphan Drugs Forum
3rd Annual Orphan Drugs Forum
working with patients and regulatory bodies
the granting of orphan designations
austerity-conscious governments
the essential role of patients
cost-cutting pressure
a different approach
attractiveness
SPECIAL FEATURES:
STREAM A: Market Access, Pricing & Reimbursement and Financing
STREAM B: Clinical Development and R&D
KEY TOPICS
Discuss how to improve processes for designation and speed up approval processes
Find out National Authorities’ interpretation of orphan drugs legislation and its impact on drug development
Learn how to effectively prepare for commercialization within Europe, the US and beyond
Explore the relevance of Patient Registries in the development of clinical research
Exchange knowledge on how to maximize partnerships and alliances
Examine the essential role of patient organisations in promoting access to treatment
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2015 | 9–11 Apr 2015 | Mandarin Oriental Washington DC Washington, District of Columbia | — | — |
| 2014 | 21–22 May 2014 | Mandarin Oriental Washington DC Washington, District of Columbia | — | — |
| 2013 | 9–11 Apr 2013 | Mandarin Oriental Washington DC Washington, District of Columbia | — | — |
| 2012 | 7–8 Jun 2012 | Vienna Austria Vienna, Austria | — | — |
| 2011 | 4–5 May 2011 | Vienna Austria Vienna, Austria | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.